A novel Phase I clinical trial design with unequal cohort sizes
Fuente:
arXiv
Enregistré dans:
| Auteur principal: | Zhu, Xiaojun |
|---|---|
| Format: | Preprint |
| Publié: |
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Equipoise calibration of clinical trial design
par: Rigat, Fabio
Publié: (2025)
par: Rigat, Fabio
Publié: (2025)
Balancing events, not patients, maximizes power of the logrank test: and other insights on unequal randomization in survival trials
par: Yung, Godwin, et autres
Publié: (2024)
par: Yung, Godwin, et autres
Publié: (2024)
Shared Keyboard: An improved Bayesian design for phase I clinical trials via Beta kernel process
par: Zhao, Jiangyan, et autres
Publié: (2026)
par: Zhao, Jiangyan, et autres
Publié: (2026)
Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
par: Silva, Rebecca B., et autres
Publié: (2025)
par: Silva, Rebecca B., et autres
Publié: (2025)
Assurance Methods for designing a clinical trial with a delayed treatment effect
par: Salsbury, James, et autres
Publié: (2023)
par: Salsbury, James, et autres
Publié: (2023)
Evaluation of clinical utility in emulated clinical trials
par: Hruza, Johannes, et autres
Publié: (2025)
par: Hruza, Johannes, et autres
Publié: (2025)
A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders
par: Xu, Xiaoming, et autres
Publié: (2024)
par: Xu, Xiaoming, et autres
Publié: (2024)
A systematic review of sample size determination in Bayesian randomized clinical trials: full Bayesian methods are rarely used
par: Marks, Yanara, et autres
Publié: (2025)
par: Marks, Yanara, et autres
Publié: (2025)
Incorporating estimands into meta-analyses of clinical trials
par: Remiro-Azócar, Antonio, et autres
Publié: (2025)
par: Remiro-Azócar, Antonio, et autres
Publié: (2025)
Benchmarking covariate-adjustment strategies for randomized clinical trials
par: Shao, Yulin, et autres
Publié: (2026)
par: Shao, Yulin, et autres
Publié: (2026)
The R.O.A.D. to clinical trial emulation
par: Bertsimas, Dimitris, et autres
Publié: (2024)
par: Bertsimas, Dimitris, et autres
Publié: (2024)
The Bayesian optimal two-stage design for clinical phase II trials based on Bayes factors
par: Kelter, Riko, et autres
Publié: (2025)
par: Kelter, Riko, et autres
Publié: (2025)
Confidence intervals for adaptive trial designs I: A methodological review
par: Robertson, David S., et autres
Publié: (2024)
par: Robertson, David S., et autres
Publié: (2024)
A cautious use of auxiliary outcomes for decision-making in randomized clinical trials
par: Russo, Massimiliano, et autres
Publié: (2025)
par: Russo, Massimiliano, et autres
Publié: (2025)
Data-driven controlled subgroup selection in clinical trials
par: Müller, Manuel M., et autres
Publié: (2025)
par: Müller, Manuel M., et autres
Publié: (2025)
Regression discontinuity design in perinatal epidemiology and birth cohort research
par: Popovic, Maja, et autres
Publié: (2022)
par: Popovic, Maja, et autres
Publié: (2022)
A multi-arm multi-stage design for trials with all pairwise testing
par: Greenstreet, Peter, et autres
Publié: (2025)
par: Greenstreet, Peter, et autres
Publié: (2025)
Response rate estimation in single-stage basket trials: A comparison of estimators that allow for borrowing across cohorts
par: Daletzakis, Antonios, et autres
Publié: (2025)
par: Daletzakis, Antonios, et autres
Publié: (2025)
Utilising high-dimensional data in randomised clinical trials: a review of methods and practice
par: Cherlin, Svetlana, et autres
Publié: (2023)
par: Cherlin, Svetlana, et autres
Publié: (2023)
Can artificial intelligence predict clinical trial outcomes?
par: Jin, Shuyi, et autres
Publié: (2024)
par: Jin, Shuyi, et autres
Publié: (2024)
Bias reduction in g-computation for covariate adjustment in randomized clinical trials
par: Zhang, Xin, et autres
Publié: (2025)
par: Zhang, Xin, et autres
Publié: (2025)
Synergy Area with FDR-controlled Evaluation (SAFE) to robustly assess safety profile in clinical trials
par: Zhan, Tianyu, et autres
Publié: (2026)
par: Zhan, Tianyu, et autres
Publié: (2026)
Eliciting prior information from clinical trials via calibrated Bayes factor
par: Demartino, Roberto Macrì, et autres
Publié: (2024)
par: Demartino, Roberto Macrì, et autres
Publié: (2024)
Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
par: Gao, Chenyin, et autres
Publié: (2024)
par: Gao, Chenyin, et autres
Publié: (2024)
Multilevel functional distributional models with application to continuous glucose monitoring in diabetes clinical trials
par: Matabuena, Marcos, et autres
Publié: (2024)
par: Matabuena, Marcos, et autres
Publié: (2024)
One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
par: Szurewsky, Chloé, et autres
Publié: (2025)
par: Szurewsky, Chloé, et autres
Publié: (2025)
A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints
par: Owen, Melody, et autres
Publié: (2025)
par: Owen, Melody, et autres
Publié: (2025)
Randomization inference for stepped-wedge designs with noncompliance with application to a palliative care pragmatic trial
par: Zhang, Jeffrey, et autres
Publié: (2025)
par: Zhang, Jeffrey, et autres
Publié: (2025)
A non-parametric U-statistic testing approach for multi-arm clinical trials with multivariate longitudinal data
par: Ghosh, Dhrubajyoti, et autres
Publié: (2024)
par: Ghosh, Dhrubajyoti, et autres
Publié: (2024)
Bayesian Optimal Phase II design with optimised stopping boundaries and response-adaptive randomisation
par: Fitchett, Connor, et autres
Publié: (2025)
par: Fitchett, Connor, et autres
Publié: (2025)
Blinded sample size re-estimation accounting for uncertainty in mid-trial estimation
par: Maeda, Hirotada, et autres
Publié: (2026)
par: Maeda, Hirotada, et autres
Publié: (2026)
Utility-based optimization of Fujikawa's basket trial design -- Pre-specified protocol of a comparison study
par: Sauer, Lukas D, et autres
Publié: (2024)
par: Sauer, Lukas D, et autres
Publié: (2024)
A Formal Theory of Survey Experiment Generalizability: Attention and Salience
par: Fu, Jiawei, et autres
Publié: (2024)
par: Fu, Jiawei, et autres
Publié: (2024)
An information metric for comparing and assessing informative interim decisions in sequential clinical trials
par: Caruso, G., et autres
Publié: (2025)
par: Caruso, G., et autres
Publié: (2025)
Combining co‐introduction with patch‐size optimization as a novel strategy to maximize seagrass restoration
par: Rens J. T. Cronau, et autres
Publié: (2025)
par: Rens J. T. Cronau, et autres
Publié: (2025)
A robust score test in g-computation for covariate adjustment in randomized clinical trials leveraging different variance estimators via influence functions
par: Zhang, Xin, et autres
Publié: (2025)
par: Zhang, Xin, et autres
Publié: (2025)
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): summary of findings and a roadmap for the future of safety analyses in clinical trials
par: Rufibach, Kaspar, et autres
Publié: (2024)
par: Rufibach, Kaspar, et autres
Publié: (2024)
Simulation-based Bayesian predictive probability of success for interim monitoring of clinical trials with competing event data: two case studies
par: Micoli, Chiara, et autres
Publié: (2024)
par: Micoli, Chiara, et autres
Publié: (2024)
Methods for non-proportional hazards in clinical trials: A systematic review
par: Bardo, Maximilian, et autres
Publié: (2023)
par: Bardo, Maximilian, et autres
Publié: (2023)
Optimal allocation of sample size for randomization-based inference from $2^K$ factorial designs
par: Ravichandran, Arun, et autres
Publié: (2023)
par: Ravichandran, Arun, et autres
Publié: (2023)
Documents similaires
-
Equipoise calibration of clinical trial design
par: Rigat, Fabio
Publié: (2025) -
Balancing events, not patients, maximizes power of the logrank test: and other insights on unequal randomization in survival trials
par: Yung, Godwin, et autres
Publié: (2024) -
Shared Keyboard: An improved Bayesian design for phase I clinical trials via Beta kernel process
par: Zhao, Jiangyan, et autres
Publié: (2026) -
Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
par: Silva, Rebecca B., et autres
Publié: (2025) -
Assurance Methods for designing a clinical trial with a delayed treatment effect
par: Salsbury, James, et autres
Publié: (2023)